ADIL
ADIL
NASDAQ · Pharmaceuticals

Adial Pharmaceuticals Inc

$4.86
-0.35 (-6.72%)
As of Sep 20, 10:47 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 8 80%
Hold 2 20%
Sell 0 0%
Price Target
Analyst Price Target +261.5% upside
Low Target $13.09
Average Target $17.57
High Target $22.70
Current Price $4.86
Current
$4.86
Target
$17.57
$13.09 $17.57 avg $22.70
Scenario Analysis
Bear Case
$13.09
169.3%
Low target
Base Case
$17.57
+261.5%
Avg target
Bull Case
$22.70
+367.1%
High target
Risk/Reward
2.2x
Favorable
Price in Context
Target vs 52W High
$17.57
-93.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%